ESC Premium Access

Continuous vs. interrupted anticoagulation for atrial fibrillation ablation patients - what do the data tell us?

Congress Presentation

About the speaker

Professor Luigi Di Biase

Albert Einstein Medical Center, The Bronx (United States of America)
29 presentations
1 follower

3 more presentations in this session

Silent brain lesions and clinically relevant bleeds - the next frontiers for making atrial fibrillation ablation safer.

Speaker: Professor L. Mont (Barcelona, ES)


Who should be considered for left atrial appendage occlusion in the era of direct anticoagulants?

Speaker: Professor M. Glikson (Jerusalem, IL)


The key question: can anticoagulation be abandoned after catheter ablation of atrial fibrillation?

Speaker: Doctor A. Verma (Montreal, CA)


Access the full session

Atrial fibrillation ablation: stroke and bleeding

Speakers: Professor L. Di Biase, Professor L. Mont, Professor M. Glikson, Doctor A. Verma

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb